Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APDNNYSEAMERICAN:FOXONASDAQ:LYTOTCMKTS:MEDH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPDNApplied DNA Sciences$4.83+7.1%$8.63$4.37▼$2,655.00$2.13M0.0641,421 shs48,992 shsFOXOFOXO Technologies$0.19-7.4%$0.84$0.18▼$13.00$1.99M3.252.85 million shs3.68 million shsLYTLytus Technologies Holdings PTV.$0.07-40.6%$0.07$0.05▼$3.20$2.18M2.212.23 million shs49.56 million shsMEDHDisaboom$0.00$0.00$0.00▼$0.00$552K2.34417,903 shsN/A7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPDNApplied DNA Sciences0.00%-8.70%-7.68%-80.60%-98.42%FOXOFOXO Technologies0.00%-14.38%-53.48%-84.80%-92.96%LYTLytus Technologies Holdings PTV.0.00%0.00%0.00%0.00%-96.61%MEDHDisaboom0.00%+14.29%+14.29%+33.33%+14.29%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPDNApplied DNA Sciences0.3778 of 5 stars0.02.00.00.02.70.00.6FOXOFOXO Technologies0.2463 of 5 stars0.03.00.00.00.00.80.6LYTLytus Technologies Holdings PTV.N/AN/AN/AN/AN/AN/AN/AN/AMEDHDisaboomN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPDNApplied DNA Sciences 0.00N/AN/AN/AFOXOFOXO Technologies 0.00N/AN/AN/ALYTLytus Technologies Holdings PTV. 0.00N/AN/AN/AMEDHDisaboom 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPDNApplied DNA Sciences$3.43M0.62N/AN/A$215.25 per share0.02FOXOFOXO Technologies$4.05M0.49N/AN/A$2.24 per share0.08LYTLytus Technologies Holdings PTV.$23.72M0.09$0.23 per share0.30$10.23 per share0.01MEDHDisaboom$890K0.62N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPDNApplied DNA Sciences-$6.99M-$537.48N/A∞N/A-194.14%-66.95%-50.34%8/6/2025 (Estimated)FOXOFOXO Technologies-$12.41MN/AN/A∞N/A-159.65%N/A-34.60%8/18/2025 (Estimated)LYTLytus Technologies Holdings PTV.$290KN/A0.00∞N/AN/AN/AN/AN/AMEDHDisaboom-$170KN/A0.00∞N/A-4.38%N/AN/AN/ALatest MEDH, LYT, FOXO, and APDN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/19/2025Q1 2025MEDHDisaboomN/A$0.01N/A$0.01N/A$0.34 million5/15/2025Q2 2025APDNApplied DNA Sciences-$45.00-$230.25-$185.25-$15.35$1.19 million$0.98 million4/1/2025Q4 2024MEDHDisaboomN/A-$0.01N/A-$0.01N/A$0.33 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPDNApplied DNA SciencesN/AN/AN/AN/AN/AFOXOFOXO TechnologiesN/AN/AN/AN/AN/ALYTLytus Technologies Holdings PTV.N/AN/AN/AN/AN/AMEDHDisaboomN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPDNApplied DNA SciencesN/A4.454.27FOXOFOXO TechnologiesN/A0.110.10LYTLytus Technologies Holdings PTV.N/AN/AN/AMEDHDisaboomN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPDNApplied DNA Sciences22.22%FOXOFOXO Technologies44.89%LYTLytus Technologies Holdings PTV.0.41%MEDHDisaboomN/AInsider OwnershipCompanyInsider OwnershipAPDNApplied DNA Sciences0.17%FOXOFOXO Technologies1.71%LYTLytus Technologies Holdings PTV.84.90%MEDHDisaboomN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPDNApplied DNA Sciences70440,000434,000OptionableFOXOFOXO Technologies310.62 million10.44 millionNot OptionableLYTLytus Technologies Holdings PTV.331.11 million3.57 millionNot OptionableMEDHDisaboom1690.50 millionN/ANot OptionableMEDH, LYT, FOXO, and APDN HeadlinesRecent News About These CompaniesMedX Holdings, Inc. (OTC: MEDH) Announces Record Q1 2025 Revenue and Strategic Advances Across Cannabis, Retail Tech, and Franchise GrowthMay 20, 2025 | globenewswire.comMedX Holdings, Inc. (OTC: MEDH) Achieves PINK Current Status, Celebrates 20 Years of Lazydaze, Launches AI-Powered Vending, and Announces Bold Expansion PlansJanuary 27, 2025 | globenewswire.comBest mesh Wi-Fi system in 2024 to banish internet black spotsOctober 24, 2024 | stuff.tvSJennifer Lawrence Has Found Fall’s Alternative PumpsOctober 24, 2024 | vogue.comVShocked Woman Finds 'Most Legendary' Piece of Internet History at Yard SaleOctober 23, 2024 | msn.comJoe Biden bumbles his way through latest gaffe ridden speech: 'Dazed and confused'October 18, 2024 | msn.com'Dazed and Confused' 30th anniversary cast reunion photos in AustinOctober 7, 2024 | mysanantonio.comMCardi B’s Paris Fashion Week Outfits Are a Lesson in Revenge DressingOctober 3, 2024 | yahoo.comJoJo Siwa’s risqué photoshoot with blinged-out jockstrap leaves some fans ‘uncomfortable’: ‘Girl please no’September 25, 2024 | nypost.comNJoJo Siwa leaves fans ‘uncomfortable’ with most risque magazine cover shoot yetSeptember 25, 2024 | news.com.auNNike's Next CEO Has One Hell of a Challenge AheadSeptember 24, 2024 | wired.comWIs The High Heel Dying A Slow Death?September 23, 2024 | elle.com.auEThe Worst Wrestling Matches From the Best WrestlersSeptember 17, 2024 | denofgeek.comDThe best mesh Wi-Fi systems in 2024: top picks for home and business useSeptember 11, 2024 | techradar.comTThe Cult-Favorite Indie Bookstore Climax Opens Its First New York OutpostSeptember 6, 2024 | vogue.comVVenice Film Festival 2024 Is Here To ServeAugust 31, 2024 | elle.com.auEDonald Glover Is Still Celebrating Short Shorts SummerAugust 27, 2024 | msn.comOne unique festival, six one-person playsAugust 27, 2024 | aspendailynews.comAMedX Holdings, Inc. (MEDH) Resumes Trading on the OTC Markets, Emerges from Expert Market DormancyAugust 22, 2024 | globenewswire.comAshley Roberts turns heads in an eye catching £345 white satin co-ord as she makes a stylish exit from Heart FMAugust 6, 2024 | dailymail.co.ukNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMEDH, LYT, FOXO, and APDN Company DescriptionsApplied DNA Sciences NASDAQ:APDN$4.83 +0.32 (+7.10%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$4.84 +0.01 (+0.31%) As of 05:56 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.FOXO Technologies NYSEAMERICAN:FOXO$0.19 -0.01 (-7.38%) Closing price 06/27/2025 04:10 PM EasternExtended Trading$0.18 0.00 (-2.14%) As of 05:56 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.Lytus Technologies Holdings PTV. NASDAQ:LYT$0.07 -0.05 (-40.59%) Closing price 03/28/2025Extended Trading$0.07 0.00 (0.00%) As of 03/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lytus Technologies Holdings PTV. Ltd. operates as a platform services company in India. The company engages in the distribution of linear content streaming/telecasting services; and development of telemedicine products. Lytus Technologies Holdings PTV. Ltd. was incorporated in 2020 and is based in Dubai, the United Arab Emirates.Disaboom OTCMKTS:MEDH$0.0008 0.00 (0.00%) As of 06/27/2025Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
